Rhythm Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
CEODavid P. Meeker
CEODavid P. Meeker
Employees283
Employees283
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees283
Employees283
RYTM Key Statistics
Market cap6.03B
Market cap6.03B
Price-Earnings ratio-31.67
Price-Earnings ratio-31.67
Dividend yield—
Dividend yield—
Average volume1.39M
Average volume1.39M
High today$90.14
High today$90.14
Low today$87.68
Low today$87.68
Open price$89.90
Open price$89.90
Volume847.14K
Volume847.14K
52 Week high$94.80
52 Week high$94.80
52 Week low$40.61
52 Week low$40.61
RYTM News
Simply Wall St 5d
Revenues Not Telling The Story For Rhythm Pharmaceuticals, Inc. After Shares Rise 33%Rhythm Pharmaceuticals, Inc. ( ) shares have continued their recent momentum with a 33% gain in the last month alone. The annual gain comes to 101% following th...
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.